
usd may pm et
summari compani one largest employe benefit organ
primari focu health benefit
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori ci marketscop see
et cfra keep hold
ci drop target
ep estim --
ci histor forward price-to-earnings averag due
integr risk regulatori scrutini
around drug rebat pbm rais
ep estim
ep vs
beat consensu oper revenu
versu prior
year period ci report first full quarter
follow decemb purchas express
script ci gener revenu
pharmaci versu adjust ep
yoy howev inorgan
growth off-set share dilut higher
interest cost new debt transit
client despit histor low valuat
remain cautiou ci share concern
synergi improv competit
deriv deal outweigh
capit cost especi given view
polit uncertainti around pbm busi
model increas /colin scarola
competit intens manag care ci taken
signific leverag integr risk associ
acquisit express script larg
pharmaci benefit manger deal like present
materi integr challeng elev leverag
level least earli ci also
above-averag risk membership loss
econom slowdown view custom base
mostli group commerci contract lose
membership unemploy rise risk
partial off-set ci divers benefit product
fiscal year end dec ep estim base cfra
oper earn histor earn report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview fifth largest employe benefit organ term revenu
compani provid health care product servic well group life accid disabl
offer broad varieti benefit plan includ medic dental behavior health pharmaci
servic product medic product includ consum direct health plan cdhp hmo prefer
provid organ ppo among other health care product servic purchas
risk-bas plan custom pay fix premium carri risk health benefit
cost exceed premium revenu administr servic aso plan arrang
manag custom access health network custom self-fund medic cost aso
custom also sometim purchas stop-loss insur maximum exposur
medic cost limit exchang insur premium
decemb roughli medic custom base
approxim risk-bas custom pay premium servic custom pay
fee administr claim access network gener self-fund
larg major medic custom commerci custom commerci
million decemb total medic membership commerci busi
compris sever type custom account includ nation account multi-st
employ -base full-tim employe typic purchas aso fund
solut market account employ gener -base full-tim
employe purchas risk-bas aso plan select account employ gener
elig employe purchas aso stop loss insur coverag risk-bas plan
commerci medic membership grew grew
addit commerci busi provid manag care servic government-sponsor
custom govern segment compris approxim medic membership
decemb gener provid risk-bas plan compani govern segment offer
medicar advantag plan medicar part plan medicaid plan contract state
texa medicar supplement plan govern medic membership grew
beyond tradit medic benefit also provid benefit plan cover pharmaceut
behavior health dental group disabl life insur number custom
particip pharmaci benefit grew million million primarili
due addit custom gain complet express script combin
decemb acquisit express script pharmaci benefit manag came cost
approxim billion cash roughli equiti dilut pre-exist holder due
new equiti consider receiv express script holder primarili result express script
deal debt increas billion decemb billion decemb
addit health care benefit gener invest incom insur float
premium revenu paid advanc risk-bas plan yet paid medic claim
oper expens decemb held roughli billion cash
invest gener net invest incom billion
competit landscap accord insur inform institut roughli health
insur compani unit state estim rank fourth total medic
membership behind aetna own
gener compet nation for-profit manag care organ well
region local health plan provider-sponsor plan
financi trend oper revenu exclud invest incom increas billion
billion reflect three-year compound annual growth rate compound-annual-growth-rate
adjust pre-tax incom per share increas reflect
three-year compound-annual-growth-rate
senior vice-president tax chief
chairman board
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
ci under-valued usd
neutral sinc april technic indic ci
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook health care
servic sub-industri next month
posit base key assumpt
 economi current
late-stag econom cycl mean
expect slowdown econom
growth mani firm within
sub-industri see sustain demand
servic even face weaker
econom condit
signific advers chang oper
competit environ health care servic
provid sub-industri recent
pressur headlin risk relat
legisl regulatori propos
medicare-for-al amazon potenti disrupt
health sector elimin
rebat believ headlin
unlik evolv real threat
profit health care servic firm
near futur
nonetheless share health care servic
under-perform broader market recent
partial due pressur certain area
laboratori servic provid labcorp
pressur
sustain headwind clinic lab test
manag pbm hurt lower level
drug price inflat increas pressur
third parti payer partial allevi
high util health care servic
firm issu find
suffici qualifi staff think
pressur may account
equiti valuat suggest
potenti upsid
see opportun health care servic
firm address take advantag
recent pressur face
exampl major pbm merg
major insur off-set pressur
ci acquir express script esrx
lab servic provid opportun
acquir smaller lab gain scale
smaller lab like falter
pressur continu signific
back topic headlin risk democrat
took control hous repres
novemb mid-term elect
result chang dynam
washington
republican-domin preced two
year mani democrat appear run
medicar platform
would like lower averag rate health care
servic henc substanti advers
impact firm sub-industri
anoth headlin risk potenti repeal
afford act instig
judg texa case rule
unconstitut oppon decis
appeal current expect
upheld upon appeal although
decis could take coupl year reach
repeal expect
impact would neg health care
servic benefit
increas insur coverag past
sever year
year-to-d march health
servic index declin vs
increas
 health servic index
increas vs decreas
base index
five-year market price perform may
note sector sub-industri inform base
past perform indic futur perform
reli upon
laboratori corpor america
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
keep target price base peer
forward ep estim remain cautiou
ci pend acquisit express script see limit sale synergi
well increas neg attent regard drug rebat discount
drive express script sale ep vs ahead
estim rais ep estim ep
estim sale rose robust gain global health care
supplement benefit unit growth forecast membership
rose commerci member increas activist investor carl
icahn own less ci share state oppos compani
pend acquisit express script plan vote deal howev
ci state deal remain track sharehold compani
schedul vote deal august /jeffrey loo cfa
ci keep target below-p
ep estim remain cautiou pend
acquisit express script esrx ep vs
ahead view aid lower tax rate sale rose driven
increas medic membership member ci commerci
care ratio mcr govern mcr lower
expect aid resumpt health insur fee better cost
control spite signific flu season encourag
solid perform ci insur busi see limit synergist sale
growth esrx transact believ deal driven primarili
cost save goal greater leverag drug firm yet note
drug price pressur past year believ third
parti payer ci alreadi abl extract better price
analyst research note compani news
et cfra keep hold opinion share cigna corpor ci
drop target ep estim
-- ci histor forward price-to-earnings averag due integr risk
regulatori scrutini around drug rebat pbm rais ep
estim ep vs
beat consensu oper revenu versu
prior year period ci report first full quarter follow
decemb purchas express script ci gener revenu
pharmaci versu adjust ep yoy howev
inorgan growth off-set share dilut higher interest cost new
debt transit client despit histor low valuat
remain cautiou ci share concern synergi improv
competit deriv deal outweigh capit
cost especi given view polit uncertainti around pbm
busi model increas /colin scarola
pm et cfra maintain rate manag firm follow medicar
ci yesterday hous democrat unveil medicar
act drove sharp stock declin manag care firm
maintain ep outlook invest rate stock howev
think bill similar one highli unlik becom law
bill would move virtual citizen medicare-lik program
elimin privat insur abil compet cover basic health
benefit view sweep chang like requir broad support
think lack million american would lose employee-sponsor
plan bill detail larg tax increas think would
face financ unlik bill increment
chang system narrowli pass despit larg democrat major
chamber far today partisan balanc senat
berni sander introduc similar bill ultim impact
manag care earn /colin scarola
pm et cfra keep hold opinion share cigna corpor ci
drop target ep estim
-- line ci long-term forward price-to-earnings averag ep vs
consensu rais ep estim
start oper revenu increas yoy driven
express script acquisit improv price medic plan
view premium rose yoy much faster growth
medic custom medic cost manag solid well total
benefit expens materi slower premium growth despit strong
oper perform quarter howev estim adjust pre-tax
incom per share around yoy due cost higher
interest expens share dilut relat deal remain
cautiou ci share convinc cost synergi increas
competit deriv deal outweigh larg capit outlay
ci rais target ep
estim line ci long-term averag forward price-to-earnings ep
vs ahead consensu rais ep estim
improv ci oper margin
oper revenu rose rose yoy improv price commerci
medic supplement benefit plan total medic membership
yoy estim premium revenu per member increas approxim
yoy faster growth medic cost per member
estim improv medic cost ratio yoy combin effect revenu
growth better cost contain increas adj pre-tax
incom far versu month despit strong
perform remain cautiou ci due pend express script
acquisit expect close year-end bring new debt
dilut ci owner /colin scarola
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim ci earn
usd quarter fiscal year ci
announc earn per share usd repres
total revenu estim fiscal year
analyst estim ci earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
